| Specific growth rate versus doubling time for quantitative characterization of tumor growth rate E Mehrara, E Forssell-Aronsson, H Ahlman, P Bernhardt Cancer research 67 (8), 3970-3975, 2007 | 256 | 2007 |
| Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice C Müller, M Bunka, S Haller, U Köster, V Groehn, P Bernhardt, ... Journal of nuclear medicine 55 (10), 1658-1664, 2014 | 202 | 2014 |
| Exendin-4–based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT D Wild, A Wicki, R Mansi, M Béhé, B Keil, P Bernhardt, G Christofori, ... Journal of Nuclear Medicine 51 (7), 1059-1067, 2010 | 191 | 2010 |
| Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry A Sundlöv, K Sjögreen-Gleisner, J Svensson, M Ljungberg, T Olsson, ... European journal of nuclear medicine and molecular imaging 44, 1480-1489, 2017 | 189 | 2017 |
| Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer C Müller, CA Umbricht, N Gracheva, VJ Tschan, G Pellegrini, P Bernhardt, ... European journal of nuclear medicine and molecular imaging 46, 1919-1930, 2019 | 151 | 2019 |
| A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours F Forrer, H Uusijärvi, C Waldherr, M Cremonesi, P Bernhardt, ... European journal of nuclear medicine and molecular imaging 31, 1257-1262, 2004 | 131 | 2004 |
| A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake L Kölby, P Bernhardt, H Ahlman, B Wängberg, V Johanson, A Wigander, ... The American journal of pathology 158 (2), 745-755, 2001 | 129 | 2001 |
| Low-energy electron emitters for targeted radiotherapy of small tumours P Bernhardt, E Forssell-Aronsson, L Jacobsson, G Skarnemark Acta Oncologica 40 (5), 602-608, 2001 | 127 | 2001 |
| Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide P Andersson, E Forssell-Aronsson, V Johanson, B Wangberg The Journal of Nuclear Medicine 37 (12), 2002, 1996 | 127 | 1996 |
| Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate C Müller, J Reber, S Haller, H Dorrer, P Bernhardt, K Zhernosekov, ... European journal of nuclear medicine and molecular imaging 41, 476-485, 2014 | 125 | 2014 |
| Electron-and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production H Uusijärvi, P Bernhardt, F Rösch, HR Maecke, E Forssell-Aronsson Journal of Nuclear Medicine 47 (5), 807-814, 2006 | 123 | 2006 |
| Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters L Kölby, P Bernhardt, AM Levin-Jakobsen, V Johanson, B Wängberg, ... British journal of cancer 89 (7), 1383-1388, 2003 | 117 | 2003 |
| Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome M Fjälling, P Andersson, E Forssell-Aronsson, J Gretarsdottir, ... Journal of Nuclear Medicine 37 (9), 1519-1521, 1996 | 117 | 1996 |
| Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment J Svensson, G Berg, B Wängberg, M Larsson, E Forssell-Aronsson, ... European journal of nuclear medicine and molecular imaging 42, 947-955, 2015 | 105 | 2015 |
| Chromogranin A as a determinant of midgut carcinoid tumour volume L Kölby, P Bernhardt, C Swärd, V Johanson, H Ahlman, ... Regulatory peptides 120 (1-3), 269-273, 2004 | 98 | 2004 |
| EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor-and PSMA-targeting ligands K Sjögreen Gleisner, N Chouin, PM Gabina, F Cicone, S Gnesin, ... European journal of nuclear medicine and molecular imaging 49 (6), 1778-1809, 2022 | 93 | 2022 |
| [177Lu-DOTA0-Tyr3]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed … C Swärd, P Bernhardt, H Ahlman, B Wängberg, E Forssell-Aronsson, ... World journal of surgery 34, 1368-1372, 2010 | 83 | 2010 |
| Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy M Larsson, P Bernhardt, JB Svensson, B Wängberg, H Ahlman, ... EJNMMI research 2, 1-13, 2012 | 77 | 2012 |
| Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors P Bernhardt, SA Benjegård, L Kölby, V Johanson, O Nilsson, H Ahlman, ... International Journal of Radiation Oncology* Biology* Physics 51 (2), 514-524, 2001 | 74 | 2001 |
| EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization … C Chiesa, K Sjogreen-Gleisner, S Walrand, L Strigari, G Flux, J Gear, ... EJNMMI physics 8, 1-44, 2021 | 73 | 2021 |
